Bellring Brands (BRBR) FY2025 results: revenue $2.3 billion, up 16.1% on the year
Bellring Brands, Inc. (BRBR) reported revenue of $2.3 billion for fiscal 2025, the year ended 30 September 2025, up 16.1% on the year before. Net income was $216 million, down 12.3%, and diluted earnings per share $1.68. The figures are the company's own, from the 10-K it filed with the SEC on 18 November 2025.
Revenue
$2.3 billion
+16.1% on the year
FY2018FY2025
Operating margin
15.4%
19.4% a year earlier
FY2018FY2025
Net income
$216 million
-12.3% on the year
FY2018FY2025
Diluted EPS
$1.68
-9.7% on the year
FY2018FY2025
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 7 new, 1 kept.
Fourth-quarter net sales rose 16.6%: Net sales were $648.2 million, up $92.4 million, with volume up 19.2% and price/mix down 2.6%. Premier Protein net sales rose 14.9%.
Fiscal-year net sales rose 16.1%: Fiscal 2025 net sales reached $2,316.6 million, with volume up 14.7% and price/mix up 1.4%. Premier Protein net sales rose 16.8% for the year.
Gross margin fell in the quarter: Gross profit was $187.4 million, or 28.9% of net sales, down 8.6%. Adjusted gross profit margin was 29.7%, against 35.9% a year earlier.
Premier RTD dollar consumption up 20.4%: Premier Protein RTD dollar consumption rose 20.4% and powder rose 16.9%, while Dymatize fell 1.5%, in the 13 weeks to September 28, 2025.
Fiscal 2026 sales and EBITDA ranges: Fiscal 2026 net sales are expected at $2.41 billion to $2.49 billion, growth of 4% to 8%, and Adjusted EBITDA of $425 million to $455 million.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Operating cash flow
261
200
216
+30.6%
Capital expenditure
4.7
1.8
1.8
+161.1%
Free cash flow
256
198
214
+29.4%
Free cash flow margin
11.0%
9.9%
12.8%
Cash from investing
-4.7
-1.8
-1.8
Cash from financing
-238
-175
-202
Depreciation and amortisation
18.6
36.5
28.3
-49.0%
Share-based compensation
22.1
21.0
14.2
+5.2%
Diluted shares, weighted
128m
132m
134m
-2.9%
Shares outstanding at period end
121m
n/a
n/a
Balance sheet
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Shareholders' equity
-454
-206
-324
Redeemable equity
n/a
0.0
0.0
Debt
1,090
840
865
+29.8%
Operating lease liabilities
26.9
4.3
6.1
+525.6%
Other liabilities
278
199
144
+40.0%
Total liabilities and equity
941
837
692
+12.4%
Fixed assets
19.0
9.2
8.5
+106.5%
Goodwill
65.9
65.9
65.9
0.0%
Intangible assets
125
142
177
-11.8%
Cash and equivalents
71.8
70.8
48.4
+1.4%
Receivables
223
220
168
+1.4%
Inventory
330
286
194
+15.5%
Other assets
106
42.8
29.5
+146.5%
Total assets
941
837
692
+12.4%
10-K for the year ended 30 September 2025, filed 18 November 2025: the filing.